secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmatrix, Inc. (PULM)
CIK:        0001574235
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001641172-25-015249
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulmatrix stockholders approve merger proposals; CSRC clearance still outstanding
--------------------------------------------------------------------------------

- All seven proposals approved by stockholders at June 16 special meeting, including issuance of shares for Cullgen merger.
- Reverse stock split authorized at ratio of 1-for-2 to 1-for-10, with final ratio to be set by board; authorized shares increased to 250M.
- Merger remains subject to CSRC approval under China's Trial Measures; Pulmatrix notes CSRC approval not yet received.
- Richard Batycky re-elected as Class II director; CBIZ CPAs ratified as auditor for FY2025 (subject to change post-merger).
- Proposal 1 (share issuance >20% and change of control) passed with 798,652 votes for, 65,788 against, 2,428 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574235/000164117225015249/0001641172-25-015249-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574235/000164117225015249/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015249

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer